(2024)
Bipolar disorder and the risk of cardiometabolic diseases, heart failure, and all-cause mortality: a population-based matched cohort study in South Korea.
SCIENTIFIC REPORTS.
14,
1
(2024)
Psychotic Disorders and the Risk of Type 2 Diabetes, Atherosclerotic Cardiovascular Diseases, and All-Cause Mortality: A Population-Based Matched Cohort Study.
DIABETES & METABOLISM JOURNAL.
-,
-
(2024)
Association between total cholesterol levels and all-cause mortality among newly diagnosed patients with cancer.
SCIENTIFIC REPORTS.
14,
1
(2024)
Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.
690,
-
(2023)
Increased risk of incident mental disorders in adults with new-onset type 1 diabetes diagnosed after the age of 19: a nationwide cohort study.
DIABETES & METABOLISM.
50,
1
(2023)
Depression, antidepressant use, and the risk of type 2 diabetes: a nationally representative cohort study.
FRONTIERS IN PSYCHIATRY.
14,
(2023)
Metabolic syndrome and the risk of abdominal aortic aneurysm: A nationwide cohort study.
ATHEROSCLEROSIS.
386,
(2023)
Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents.
FRONTIERS IN ONCOLOGY.
13,
(2023)
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
DIABETES & METABOLISM JOURNAL.
47,
5
(2023)
Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study.
DIABETES & METABOLISM JOURNAL.
47,
5
(2023)
Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD.
SCIENTIFIC REPORTS.
13,
1
(2023)
Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma.
AMERICAN JOURNAL OF CANCER RESEARCH.
13,
5
(2023)
Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study.
FRONTIERS IN ENDOCRINOLOGY.
14,
(2023)
Association of body weight change with all-cause and cause-specific mortality: A nationwide population-based study.
DIABETES RESEARCH AND CLINICAL PRACTICE.
199,
(2023)
Low Skeletal Muscle Mass Accompanied by Abdominal Obesity Additively Increases the Risk of Incident Type 2 Diabetes.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM.
108,
5
(2023)
Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019.
DIABETES & METABOLISM JOURNAL.
47,
2
(2023)
Extracellular Vesicles Derived from Three-Dimensional-Cultured Human Umbilical Cord Blood Mesenchymal Stem Cells Prevent Inflammation and Dedifferentiation in Pancreatic Islets.
STEM CELLS INTERNATIONAL.
2023,
(2023)
Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
CANCERS.
15,
4
(2023)
MAFLD and NAFLD in the prediction of incident chronic kidney disease.
SCIENTIFIC REPORTS.
13,
1
(2022)
The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study.
DIABETES RESEARCH AND CLINICAL PRACTICE.
194,
-
단행본
(2023)
당뇨병학(6판).
범문에듀케이션.
공동
(2023)
연속혈당측정을 이용한 혈당 조절 길잡이(인슐린 주사 요법 편).
도서출판 마루.
공동
(2023)
연속혈당측정을 이용한 혈당 조절 길잡이(인슐린 펌프/자동 인슐린 주입 편).
도서출판 마루.
공동
(2022)
자동 인슐린 주입 펌프의 시작.
도서출판 마루.
공동
(2020)
연속혈당측정을 이용한 혈당 조절 길잡이.
도서출판 마루.
공동
(2020)
술술 풀리는 쉬운 당 조절법 [연속혈당측정기 고수되기].
도서출판 마루.
공동
(2018)
당뇨병학(제5판).
범문에듀케이션.
공동
특허/프로그램
단말 장치를 이용하여 환자의 혈당을 관리하는 방법, 장치 및 컴퓨터 프로그램.
10-2017-0085923.
20200303.
대한민국
췌도세포 이식용 세포이식물 및 이의 용도.
10-2016-0117876.
20171113.
대한민국
학술회의논문
(2023)
Connected insulin pen (DIACONN P8을 중심으로).
2차 인슐린 펌프 워크샵.
대한민국
(2023)
GLP-1RA and diabetes/obesity.
ISCP 2023 with KSCVP & KSCP.
대한민국
(2023)
MAFLD and NAFLD in the Prediction of CKD, DM, and Diastolic Dysfunction.
2023 ICOMES.
대한민국
(2023)
Automated insulin delivery in T2DM.
제36차 대한당뇨병학회 춘계학술대회.
대한민국
(2023)
연속혈당측정은 언제, 누구에게, 어떻게?.
제25회 대한당뇨병학회 호남지회 춘계학술대회.
대한민국
(2020)
Overview; Real-time CGM in 2020.
AOCE-SICEM 2020.
대한민국
(2020)
Dysglycemia, Glucose Variability and diastolic Dysfunction.
2020 추계 심포지엄 : Navigators in CardioMetabolic Syndrome.
대한민국
(2020)
내 환자에게 지속혈당 모니터링 기기 적용해 보고 싶어요.
대한내분비학회 제51회 연수강좌.
대한민국
(2020)
Interpretation of CGM; 2019 international consensus.
제33차 대한당뇨병학회 춘계학술대회.
대한민국
(2019)
CGMS: Why, When, Who and How?.
제7회 대한당뇨병학회 충청지회 당뇨병교육자 세미나.
대한민국
(2019)
CV Benefit of SGL T2 Inhibitor : Cardiometabolic Mechanisms Beyond its Hemodynamic Effect.
대한심장학회 제63차 추계학술대회.
대한민국
(2019)
CGMS: Why, When, Who and How?.
The 18th Postgraduate Course of Diabetes.
대한민국
(2019)
The continuing role of islet transplantation in the management of type 1 diabetes complicated by hypoglycemic unawareness.
2019 Asia Islet Biology & Incretin Symposium.
대한민국
(2019)
The Many Faces of SGLT2 Inhibitors : Are They Antidiabetic or Anti-CVDs?.
2019 춘계심혈관 통합학술대회.
대한민국
(2017)
Pathophysiology of T1DM.
The 16th Postgraduate course of diabetes.
대한민국
(2017)
Management of diabetes in liver transplantation.
2017 대한간이식연구학회 추계학술대회.
대한민국
(2017)
Lipid Metabolism in Type 1 and Insulin-Treated Type 2 Diabetes.
ICOLA 2017.
대한민국
(2017)
연속혈당시스템을 이용한 혈당 관리.
제26차 당뇨병 교육자 세미나.
대한민국
(2017)
Nocturnal hypoglycemia: Endocrine disease and sleep.
2017년 제14회 대한수면연구학회 학술대회 및 보수교육.
대한민국
